Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Oct 7 - Oct 12
This phase 3 trial directly compares CagriSema 2.4 mg/2.4 mg against tirzepatide 15 mg in approximately 800 adults with obesity
Outstanding purity & consistency
The options may be chosen on the product page SS-31 Nasal Spray 152.23 299.46Price range: 152.23 through 299.46 This product has multiple variants
Both compound classes are contraindicated in active malignancy by clinical convention, given IGF-1's mitogenic properties
Or 5 mg
US$ 27.91
US$ 23.09
US$ 23.54
US$ 29.22
US$ 26.96
US$ 22.20
